348 related articles for article (PubMed ID: 37985748)
41. [Gut microbiota and efficacy of cancer therapies].
Vétizou M; Daillère R; Zitvogel L
Biol Aujourdhui; 2017; 211(1):51-67. PubMed ID: 28682227
[TBL] [Abstract][Full Text] [Related]
42. Human microbiota and effectiveness of cancer chemotherapy.
Shvets YV; Lukianova NY; Chekhun VF
Exp Oncol; 2020 Jun; 42(2):82-93. PubMed ID: 32602287
[TBL] [Abstract][Full Text] [Related]
43. Human gut microbiota plays a role in the metabolism of drugs.
Jourova L; Anzenbacher P; Anzenbacherova E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):317-26. PubMed ID: 27485182
[TBL] [Abstract][Full Text] [Related]
44. Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer.
Di Modica M; Gargari G; Regondi V; Bonizzi A; Arioli S; Belmonte B; De Cecco L; Fasano E; Bianchi F; Bertolotti A; Tripodo C; Villani L; Corsi F; Guglielmetti S; Balsari A; Triulzi T; Tagliabue E
Cancer Res; 2021 Apr; 81(8):2195-2206. PubMed ID: 33483370
[TBL] [Abstract][Full Text] [Related]
45. The pint- sized powerhouse: Illuminating the mighty role of the gut microbiome in improving the outcome of anti- cancer therapy.
Chattopadhyay I; Nandi D; Nag A
Semin Cancer Biol; 2021 May; 70():98-111. PubMed ID: 32739479
[TBL] [Abstract][Full Text] [Related]
46. The impact of modulating the gastrointestinal microbiota in cancer patients.
Morkūnas E; Skiecevičienė J; Kupčinskas J
Best Pract Res Clin Gastroenterol; 2020; 48-49():101700. PubMed ID: 33317795
[TBL] [Abstract][Full Text] [Related]
47. The Gut Microbiota Impact Cancer Etiology through "Phase IV Metabolism" of Xenobiotics and Endobiotics.
Ervin SM; Redinbo MR
Cancer Prev Res (Phila); 2020 Aug; 13(8):635-642. PubMed ID: 32611614
[TBL] [Abstract][Full Text] [Related]
48. Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery.
Kamath S; Stringer AM; Prestidge CA; Joyce P
Expert Opin Drug Deliv; 2023; 20(10):1315-1331. PubMed ID: 37405390
[TBL] [Abstract][Full Text] [Related]
49. Fecal microbiota transplantation in cancer management: Current status and perspectives.
Chen D; Wu J; Jin D; Wang B; Cao H
Int J Cancer; 2019 Oct; 145(8):2021-2031. PubMed ID: 30458058
[TBL] [Abstract][Full Text] [Related]
50. Bugs as Drugs: Understanding the Linkage between Gut Microbiota and Cancer Treatment.
Rana D; Salave S; Perla A; Nadkarni A; Kolhe S; Jindal AB; Mandoli A; Dwivedi P; Benival D
Curr Drug Targets; 2022; 23(9):869-888. PubMed ID: 35264088
[TBL] [Abstract][Full Text] [Related]
51. Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications.
Zhao LY; Mei JX; Yu G; Lei L; Zhang WH; Liu K; Chen XL; Kołat D; Yang K; Hu JK
Signal Transduct Target Ther; 2023 May; 8(1):201. PubMed ID: 37179402
[TBL] [Abstract][Full Text] [Related]
52. Pharmacomicrobiomics in Western Medicine and Traditional Chinese Medicine in Type 2 Diabetes.
Chu N; Chan JCN; Chow E
Front Endocrinol (Lausanne); 2022; 13():857090. PubMed ID: 35600606
[TBL] [Abstract][Full Text] [Related]
53. Pharmacomicrobiomics informs clinical pharmacogenomics.
Katsila T; Balasopoulou A; Tsagaraki I; Patrinos GP
Pharmacogenomics; 2019 Jul; 20(10):731-739. PubMed ID: 31368841
[No Abstract] [Full Text] [Related]
54. Personalized Nutrition Through The Gut Microbiota: Current Insights And Future Perspectives.
Vandeputte D
Nutr Rev; 2020 Dec; 78(12 Suppl 2):66-74. PubMed ID: 33259623
[TBL] [Abstract][Full Text] [Related]
55. Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes.
Ting NL; Lau HC; Yu J
Gut; 2022 Jul; 71(7):1412-1425. PubMed ID: 35277453
[TBL] [Abstract][Full Text] [Related]
56. Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes.
Saad R; Rizkallah MR; Aziz RK
Gut Pathog; 2012 Nov; 4(1):16. PubMed ID: 23194438
[TBL] [Abstract][Full Text] [Related]
57. Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota.
Lindell AE; Zimmermann-Kogadeeva M; Patil KR
Nat Rev Microbiol; 2022 Jul; 20(7):431-443. PubMed ID: 35102308
[TBL] [Abstract][Full Text] [Related]
58. The mutual interplay of gut microbiota, diet and human disease.
Illiano P; Brambilla R; Parolini C
FEBS J; 2020 Mar; 287(5):833-855. PubMed ID: 31955527
[TBL] [Abstract][Full Text] [Related]
59. The microbiome and cancer for clinicians.
Picardo SL; Coburn B; Hansen AR
Crit Rev Oncol Hematol; 2019 Sep; 141():1-12. PubMed ID: 31202124
[TBL] [Abstract][Full Text] [Related]
60. Gut Microbiome and Response to Cardiovascular Drugs.
Tuteja S; Ferguson JF
Circ Genom Precis Med; 2019 Sep; 12(9):421-429. PubMed ID: 31462078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
